3-Alkyl-(5,5′-diphenyl)imidazolidinediones as new cannabinoid receptor ligands

3-Alkyl-(5,5′-diphenyl)imidazolidinediones as new cannabinoid receptor ligands Substituted 5,5‘-Diphenyl-2-thioxoimidazolidin-4-one as CB₁ Cannabinoid Receptor Ligands:  Synthesis and Pharmacological Evaluation Synthesis and Activity of 1,3,5-Triphenylimidazolidine-2,4-diones and 1,3,5-Triphenyl-2-thioxoimidazolidin-4-ones: Characterization of New CB₁ Cannabinoid Receptor Inverse Agonists/Antagonists Novel sterically hindered cannabinoid CB1 receptor ligands 1-Benzhydryl-3-phenylurea and 1-Benzhydryl-3-phenylthiourea Derivatives:  New Templates among the CB₁ Cannabinoid Receptor Inverse Agonists Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB 1 receptor ligand antagonists Discovery of 1,1-dioxo-1,2,6-thiadiazine-5-carboxamide derivatives as cannabinoid-like molecules with agonist and antagonist activity Substituted 2-Thioxoimidazolidin-4-ones and Imidazolidine-2,4-diones as Fatty Acid Amide Hydrolase Inhibitors Templates Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists